These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8672987

  • 1. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
    Murray SC, Sandler RS, Keku TO, Lyles CM, Millikan RC, Bangdiwala SI, Kupper LL, Jiang W, Ulshen MH.
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):715-20. PubMed ID: 8672987
    [Abstract] [Full Text] [Related]

  • 2. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
    Keku TO, Galanko JA, Murray SC, Woosley JT, Sandler RS.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
    [Abstract] [Full Text] [Related]

  • 3. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
    Lyles CM, Sandler RS, Keku TO, Kupper LL, Millikan RC, Murray SC, Bangdiwala SI, Ulshen MH.
    Cancer Epidemiol Biomarkers Prev; 1994 Nov; 3(7):597-605. PubMed ID: 7827591
    [Abstract] [Full Text] [Related]

  • 4. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
    Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, Elmer P, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
    [Abstract] [Full Text] [Related]

  • 5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
    Kilias D, Macrae FA, Sharpe K, Young GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
    [Abstract] [Full Text] [Related]

  • 6. Quantification of proliferating cell nuclear antigen in large intestinal crypt by computer-assisted image analysis.
    Lin HC, Sotnikov AV, Fosdick L, Bostick RM, Willett WC.
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):109-14. PubMed ID: 8850271
    [Abstract] [Full Text] [Related]

  • 7. Reliability of whole crypt mitotic count as a measure of cellular proliferation in rectal biopsies.
    Tosteson TD, Karagas MR, Rothstein R, Ahnen DJ, Greenberg ER.
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):437-9. PubMed ID: 8781739
    [Abstract] [Full Text] [Related]

  • 8. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS, Baron JA, Tosteson TD, Mandel JS, Haile RW.
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [Abstract] [Full Text] [Related]

  • 9. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
    Einspahr J, Alberts D, Xie T, Ritchie J, Earnest D, Hixson L, Powell M, Roe D, Grogan T.
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
    [Abstract] [Full Text] [Related]

  • 10. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E, Kordek R, Biernat W, Tureaud J, Liberski PP, Majumdar AP.
    Hepatogastroenterology; 1997 Jun; 44(14):435-40. PubMed ID: 9164515
    [Abstract] [Full Text] [Related]

  • 11. Effects of milk and milk products on rectal mucosal cell proliferation in humans.
    Karagas MR, Tosteson TD, Greenberg ER, Rothstein RI, Roebuck BD, Herrin M, Ahnen D.
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):757-66. PubMed ID: 9752983
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological use of rectal proliferation measures.
    Baron JA, Wargovich MJ, Tosteson TD, Sandler R, Haile R, Summers R, van Stolk R, Rothstein R, Weiss J.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(1):57-61. PubMed ID: 7894325
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
    McShane LM, Kulldorff M, Wargovich MJ, Woods C, Purewal M, Freedman LS, Corle DK, Burt RW, Mateski DJ, Lawson M, Lanza E, O'Brien B, Lake W, Moler J, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
    [Abstract] [Full Text] [Related]

  • 14. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G, Paganelli GM, Santucci R, Brandi G, Barbara L.
    J Cell Biochem Suppl; 1994 Jul; 19():55-60. PubMed ID: 7823606
    [Abstract] [Full Text] [Related]

  • 15. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies.
    Paspatis GA, Zizi A, Chlouverakis GJ, Giannikaki ES, Vasilakaki T, Elemenoglou I, Karamanolis DG.
    Am J Gastroenterol; 1998 Sep; 93(9):1472-7. PubMed ID: 9732928
    [Abstract] [Full Text] [Related]

  • 16. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M, Candelaresi G, Rossini FP.
    Cancer Epidemiol Biomarkers Prev; 1993 Sep; 2(4):363-7. PubMed ID: 8102291
    [Abstract] [Full Text] [Related]

  • 17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS.
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [Abstract] [Full Text] [Related]

  • 18. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
    Macrae FA, Kilias D, Sharpe K, Hughes N, Young GP, MacLennan R.
    J Cell Biochem Suppl; 1994 Jun; 19():84-90. PubMed ID: 7823610
    [Abstract] [Full Text] [Related]

  • 19. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
    Krishnan K, Aoki T, Ruffin MT, Normolle DP, Boland CR, Brenner DE.
    Cancer Detect Prev; 2004 Jun; 28(2):107-13. PubMed ID: 15068834
    [Abstract] [Full Text] [Related]

  • 20. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.
    Martin C, Connelly A, Keku TO, Mountcastle SB, Galanko J, Woosley JT, Schliebe B, Lund PK, Sandler RS.
    Gastroenterology; 2002 Dec; 123(6):1770-7. PubMed ID: 12454832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.